Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:870165.
doi: 10.1155/2014/870165. Epub 2014 Mar 25.

The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance

Affiliations

The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance

Lou Rose Malamug et al. Scientifica (Cairo). 2014.

Abstract

Infection, for example, Helicobacter pylori (H. pylori), has been thought to play a role in the pathogenesis of type 2 diabetes mellitus (T2DM). Our aim was to determine the role of H. pylori infection in glucose metabolism in an American cohort. We examined data from 4,136 non-Hispanic white (NHW), non-Hispanic black (NHB), and Mexican Americans (MA) aged 18 and over from the NHANES 1999-2000 cohort. We calculated the odds ratios for states of glucose tolerance based on the H. pylori status. We calculated and compared homeostatic model assessment insulin resistance (HOMA-IR) and beta cell function (HOMA-B) in subjects without diabetes based on the H. pylori status. The results were adjusted for age, body mass index (BMI), poverty index, education, alcohol consumption, tobacco use, and physical activity. The H. pylori status was not a risk factor for abnormal glucose tolerance. After adjustment for age and BMI and also adjustment for all covariates, no difference was found in either HOMA-IR or HOMA-B in all ethnic and gender groups except for a marginally significant difference in HOMA-IR in NHB females. H. pylori infection was not a risk factor for abnormal glucose tolerance, nor plays a major role in insulin resistance or beta cell dysfunction.

PubMed Disclaimer

References

    1. Guo X, Zhao B-H, Zhang M-X. Risk factors of Helicobacter pylori infection among adults in Northern China. Hepato-Gastroenterology. 2011;58(106):306–310. - PubMed
    1. Ataseven H, Demir M, Gen R. Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. Southern Medical Journal. 2010;103(10):988–992. - PubMed
    1. Imai J, Yamada T, Saito T, et al. Eradication of insulin resistance. The Lancet. 2009;374(9685):p. 264. - PubMed
    1. Akanuma M, Yanai A, Sakamoto K, et al. Influence of Helicobacter pylori eradication on the management of type 2 diabetes. Hepato-Gastroenterology. 2012;59(114):641–645. - PubMed
    1. Aslan M, Nazligul Y, Horoz M, et al. Serum prolidase activity and oxidative status in Helicobacter pylori infection. Clinical Biochemistry. 2007;40(1-2):37–40. - PubMed

LinkOut - more resources